Collagen Peptide Supplementation Linked to Increased Muscle Collagen During Strength Training

Saturday, July 11th, 2026 - A new study published in a peer-reviewed journal found that taking specific collagen peptides while engaging in resistance training led to a greater increase in type I collagen within muscle tissue, according to a report from MindBodyGreen. The research adds to a growing body of evidence examining whether oral collagen supplements can influence muscle structure beyond their well-known role in skin and joint health.

Researchers observed that participants who consumed collagen peptides alongside a structured strength training program showed measurable increases in intramuscular collagen type I compared to those who trained without supplementation. Type I collagen is the primary structural protein in connective tissue and plays a role in muscle integrity and force transmission.

Study Details and Limitations

The study, whose full methodology and sample size were not detailed in the news report, focused on collagen peptides specifically rather than general protein supplements. Investigators measured collagen deposition directly from muscle biopsy samples, providing what researchers described as direct evidence of structural change rather than relying on indirect markers.

Clinicians caution that while the findings are mechanistically interesting, the study does not establish whether increased intramuscular collagen translates to improved strength, muscle size, or functional outcomes. The supplement industry has long marketed collagen peptides for joint and skin health, but muscle-specific claims have faced scrutiny from regulators for lacking robust human trial data.

Regulatory Context

The study arrives as the U.S. Food and Drug Administration continues to evaluate the regulatory status of peptide products marketed for health and performance purposes. Collagen peptides, which are generally recognized as safe as food ingredients, occupy a different regulatory category than prescription peptide drugs or compounded peptide therapies.

The FDA has not issued specific guidance on collagen peptide supplementation for muscle health, and the agency generally does not review dietary supplement efficacy claims before products reach the market.

Related Reading

• For ongoing coverage of peptide regulation and compounding policy, see Medriva's /tracker/
• For clinical trial methodology and evidence standards, see /clinical-review-methodology/